These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24386216)
1. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations. Son M; Baek A; Sakkiah S; Park C; John S; Lee KW PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216 [TBL] [Abstract][Full Text] [Related]
3. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening. Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841 [TBL] [Abstract][Full Text] [Related]
4. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening. Lin SH; Huang KJ; Weng CF; Shiuan D Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618 [TBL] [Abstract][Full Text] [Related]
5. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking. Islam B; Sharma C; Adem A; Aburawi E; Ojha S Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462 [TBL] [Abstract][Full Text] [Related]
6. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Istvan ES Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413 [TBL] [Abstract][Full Text] [Related]
7. The structure of the catalytic portion of human HMG-CoA reductase. Istvan ES; Deisenhofer J Biochim Biophys Acta; 2000 Dec; 1529(1-3):9-18. PubMed ID: 11111074 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924 [TBL] [Abstract][Full Text] [Related]
9. Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis. Gesto DS; Cerqueira NM; Ramos MJ; Fernandes PA J Mol Model; 2014 Apr; 20(4):2178. PubMed ID: 24671303 [TBL] [Abstract][Full Text] [Related]
10. Discovery and quantitative structure-activity relationship study of lepidopteran HMG-CoA reductase inhibitors as selective insecticides. Zang YY; Li YM; Yin Y; Chen SS; Kai ZP Pest Manag Sci; 2017 Sep; 73(9):1944-1952. PubMed ID: 28247468 [TBL] [Abstract][Full Text] [Related]
11. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking. Karthik MV; Satya Deepak MV; Shukla P Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940 [TBL] [Abstract][Full Text] [Related]
12. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone. Pak VV; Koo M; Kim MJ; Yun L; Kwon DY Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732 [TBL] [Abstract][Full Text] [Related]
13. Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations. da Costa RF; Freire VN; Bezerra EM; Cavada BS; Caetano EW; de Lima Filho JL; Albuquerque EL Phys Chem Chem Phys; 2012 Jan; 14(4):1389-98. PubMed ID: 22159045 [TBL] [Abstract][Full Text] [Related]
14. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme. Leopoldini M; Malaj N; Toscano M; Sindona G; Russo N J Agric Food Chem; 2010 Oct; 58(19):10768-73. PubMed ID: 20843083 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by sterol regulatory element binding protein cleavage-activating protein requires four phenylalanine residues in span 6 of HMG-CoA reductase transmembrane domain. Xu L; Simoni RD Arch Biochem Biophys; 2003 Jun; 414(2):232-43. PubMed ID: 12781775 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA). Thilagavathi R; Kumar R; Aparna V; Sobhia ME; Gopalakrishnan B; Chakraborti AK Bioorg Med Chem Lett; 2005 Feb; 15(4):1027-32. PubMed ID: 15686906 [TBL] [Abstract][Full Text] [Related]
17. Structure-based design and screen of novel inhibitors for class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae. Li D; Gui J; Li Y; Feng L; Han X; Sun Y; Sun T; Chen Z; Cao Y; Zhang Y; Zhou L; Hu X; Ren Y; Wan J J Chem Inf Model; 2012 Jul; 52(7):1833-41. PubMed ID: 22725250 [TBL] [Abstract][Full Text] [Related]
18. Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps. Wang Z; Yan A Mol Divers; 2011 Aug; 15(3):655-63. PubMed ID: 21072588 [TBL] [Abstract][Full Text] [Related]
19. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae. Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257 [TBL] [Abstract][Full Text] [Related]
20. Pharmacophore Modeling and Binding Affinity of Secondary Metabolites from Aulifa DL; Amirah SR; Rahayu D; Megantara S; Muchtaridi M Molecules; 2024 Jun; 29(13):. PubMed ID: 38998937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]